GlassScriptPhysician profile
Brea E Loewit Abbey
NPI 1447751664
$2,099.30
in general payments reported to CMS, 2019-2025
18 companies · $605 in 2025
The $605 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $318 · 2022: $342 · 2023: $553 · 2024: $281 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,278 · Education: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,277.59 |
| Education | $161.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $498.03 | 2023-2025 | |
| Biohaven Pharmaceuticals, INC. | $317.57 | 2021 | |
| Astellas Pharma US INC | $268.12 | 2023-2025 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $212.91 | 2022 | |
| Mayne Pharma Commercial LLC | $180.80 | 2023-2025 | |
| Abbvie INC. | $118.63 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $103.32 | 2023-2025 | |
| Organon LLC | $102.60 | 2023-2025 | Nexplanon, Nuvaring |
| Sumitomo Pharma America, INC. | $59.39 | 2023-2025 | Myfembree |
| Merck Sharp & Dohme LLC | $42.81 | 2023-2024 | Gardasil 9, Gardasil, Capvaxive |
| Agile Therapeutics, INC. | $39.16 | 2022-2024 | Twirla |
| Scynexis, INC. | $37.47 | 2022 | |
| Exact Sciences Corporation | $25.99 | 2025 | Cologuard Collection Kit |
| Myovant Sciences INC. | $25.59 | 2022 | |
| Millicent US INC | $22.24 | 2025 | Femlyv |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $18.00 | 2024 | Slynd |
| Therapeuticsmd, INC. | $13.76 | 2022 | |
| Coopersurgical, INC. | $12.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brea Loewit Abbey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.